| Ident. | Authors (with country if any) | Title |
|---|
| 005734 (2001) |
Anne-Sophie Vercoutter-Edouart [France] ; Jérome Lemoine [France] ; Xuefen Le Bourhis [France] ; Hornez Louis [France] ; Bénoni Boilly [France] ; Victor Nurcombe [Australie] ; Francoise Revillion [France] ; Jean-Philippe Peyrat [France] ; Hubert Hondermarck [France] | Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells |
| 005873 (2001) |
Kaori Koyama [Australie] ; Kathy Myles [Australie] ; Robin Smith [Australie] ; Zygmunt Krozowski [Australie] | Expression of the 11 β-hydroxysteroid dehydrogenase type II enzyme in breast tumors and modulation of activity and cell growth in PMC42 cells |
| 005A62 (2000) |
S. R. Lakhani [Royaume-Uni] ; B. A. Gusterson [Royaume-Uni] ; J. Jacquemier [France] ; J. P. Sloane [Royaume-Uni] ; T. J. Anderson [Royaume-Uni] ; M. J. V. De Vijver ; D. Venter [Australie] ; A. Freeman [Royaume-Uni] ; A. Antoniou [Royaume-Uni] ; L. Mcguffog [Royaume-Uni] ; E. Smyth [Royaume-Uni] ; C. M. Steel [Royaume-Uni] ; N. Haites [Royaume-Uni] ; R. J. Scott [Australie] ; D. Goldgar [France] ; S. Neuhausen [États-Unis] ; P. A. Daly ; W. Ormiston ; R. Mcmanus ; S. Scherneck ; B. A. J. Ponder ; P. A. Futreal ; J. Peto [Royaume-Uni] ; D. Stoppa-Lyonnet ; Y.-J. Bignon ; J. P. Struewing ; D. T. Bishop ; J. G. M. Klijn ; P. Devilee ; C. J. Cornelisse ; C. Lasset ; G. Lenoir [France] ; R. B. Barkardottir ; V. Egilsson ; U. Hamann ; J. Chang-Claude ; H. Sobol [France] ; B. Weber ; D. F. Easton [Royaume-Uni] ; M. R. Stratton [Royaume-Uni] | The pathology of familial breast cancer : Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2 |
| 005C94 (2000) |
E. N. Imyanitov [Russie, Australie] ; A. V. Togo [Russie] ; E. N. Suspitsin [Russie] ; M. Y. Grigoriev [Russie] ; K. M. Pozharisski [Russie] ; E. A. Turkevich [Russie] ; K. P. Hanson [Russie] ; N. K. Hayward [Australie] ; G. Chenevix-Trench [Russie] ; C. Theillet [France] ; M. F. Lavin [Australie] | Evidence for microsatellite instability in bilateral breast carcinomas |
| 005D87 (2000) |
P. E. L Nning [Norvège, Italie, Australie, France, États-Unis, Argentine, Pays-Bas] ; E. Bajetta ; R. Murray ; M. Tubiana-Hulin ; P. D. Eisenberg ; E. Mickiewicz ; L. Celio ; P. Pitt ; M. Mita ; N. K. Aaronson ; C. Fowst ; A. Arkhipov ; E. Di Salle ; A. Polli ; G. Massimini | Activity of Exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors : A Phase II Trial |
| 005F29 (1999) |
S. Chan [Royaume-Uni, États-Unis, Allemagne, Canada, Hongrie, Belgique, Afrique du Sud, Colombie, Espagne, Slovaquie, Italie, Australie, France, Irlande (pays)] ; K. Friedrichs ; D. Noel ; T. Pinter ; S. Van Belle ; D. Vorobiof ; R. Duarte ; M. G. Gil ; I. Bodrogi ; E. Murray ; L. Yelle ; G. Von Minckwitz ; S. Korec ; P. Simmonds ; F. Buzzi ; R. G. Mancha ; G. Richardson ; E. Walpole ; M. Ronzoni ; M. Murawsky ; M. Alakl ; A. Riva ; J. Crown | Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer |
| 006330 (1998) |
S. R. Lakhani [Royaume-Uni] ; J. Jacquemier [France] ; J. P. Sloane [Royaume-Uni] ; B. A. Gusterson [Royaume-Uni] ; T. J. Anderson [Royaume-Uni] ; M. J. V. De Vijver [Pays-Bas] ; L. M. Farid [États-Unis] ; D. Venter [Australie] ; A. Antoniou [Royaume-Uni] ; A. Storfer-Isser ; E. Smyth [Royaume-Uni] ; C. M. Steel [Royaume-Uni] ; N. Haites ; R. J. Scott ; D. Goldgar ; S. Neuhausen ; P. A. Daly ; W. Ormiston ; R. Mcmanus ; S. Scherneck ; B. A. J. Ponder ; D. Ford ; J. Peto ; D. Stoppa-Lyonnet ; Y.-J. Bignon ; J. P. Struewing ; N. K. Spurr ; D. T. Bishop ; J. G. M. Klijn ; P. Devilee | Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations |
| 006368 (1998) |
M. Gershanovich [Russie] ; H. A. Chaudri [Suisse] ; D. Campos [Argentine] ; H. Lurie [Israël] ; A. Bonaventura [Australie] ; M. Jeffrey [Nouvelle-Zélande] ; F. Buzzi [Italie] ; I. Bodrogi [Hongrie] ; H. Ludwig [Autriche] ; P. Reichardt [Allemagne] ; N. O'Higgins [Irlande (pays)] ; G. Romieu [France] ; P. Friederich [Suisse] ; M. Lassus [Suisse] | Letrozole, a new oral aromatase inhibitor : Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer |
| 006388 (1998) |
J. A. Byrne [Australie] ; C. R. Nourse [Australie] ; P. Basset [France] ; P. Gunning [Australie] | Identification of homo- and heteromeric interactions between members of the breast carcinoma-associated D52 protein family using the yeast two-hybrid system |
| 006426 (1998) |
O. W. J. Prall [Australie] ; E. M. Rogan [Australie] ; R. L. Sutherland [Australie] | Estrogen regulation of cell cycle progression in breast cancer cells |
| 006477 (1998) |
H. C. Mertani [France, Singapour] ; T. Garcia-Caballero [Espagne] ; A. Lambert [France] ; F. Gerard [France] ; C. Palayer [France] ; J.-M. Boutin [Canada] ; B. K. Vonderhaar [États-Unis] ; M. J. Waters [Australie] ; P. E. Lobie [Singapour] ; G. Morel [France] | Cellular expression of growth hormone and prolactin receptors in human breast disorders |
| 006592 (1997) |
B. Thürlimann [Suisse] ; R. Paridaens [Belgique] ; D. Serin [France] ; J. Bonneterre [France] ; H. Roche [France] ; R. Murray [Australie] ; E. Di Salle [Italie] ; S. Lanzalone [Italie] ; M. G. Zurlo [Italie] ; G. Piscitelli [Italie] | Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide : a phase II multicentre multinational study |
| 006737 (1997) |
J.-L. Baert [France] ; D. Monte [France] ; E. A. Musgrove [Australie] ; O. Albagli [France] ; R. L. Sutherland [Australie] ; Y. De Launoit [France] | Expression of the PEA3 group of ETS-related transcription factors in human breast-cancer cells |
| 006778 (1997) |
C. J. Ormandy [Australie] ; R. E. Hall ; D. L. Manning [Royaume-Uni] ; J. F. R. Robertson [Royaume-Uni] ; R. W. Blamey [Royaume-Uni] ; P. A. Kelly [France] ; R. I. Nicholson [Royaume-Uni] ; R. L. Sutherland | Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer |
| 006948 (1996) |
M. Perrot-Applanat [France] | Estrogen receptors in the cardiovascular system |
| 006962 (1996) |
F. Courjal [France] ; G. Louason [France] ; P. Speiser [Australie] ; D. Katsaros [Italie] ; R. Zeillinger [Australie] ; C. Theillet [France] | Cyclin gene amplification and overexpression in breast and ovarian cancers : Evidence for the selection of cylin D1 in breast and cyclin E in ovarian tumors |
| 006C18 (1993) |
C. J. Ormandy [Australie] ; C. S. L. Lee [Australie] ; P. A. Kelly [France] ; R. L. Sutherland [Australie] | Regulation of prolactin receptor expression by the tumour promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells |
| 006C88 (1993) |
R. L. Sutherland [Australie] ; C. K. W. Watts ; E. A. Musgrove | Cyclin gene expression and growth control in normal and neoplastic human breast epithelium |
| 006D26 (1992) |
C. J. Ormandy [Australie] ; A. De Fazio ; P. A. Kelly [France] ; R. L. Sutherland | Transcriptional regulation of prolactin receptor gene expression by sodium butyrate in MCF-7 human breast cancer cells |
| 006D30 (1992) |
C. J. Ormandy [Australie] ; J. Graham [Australie] ; P. A. Kelly [France] ; C. L. Clarke [Australie] ; R. L. Sutherland [Australie] | The effect of progestins on prolactin receptor gene transcription in human breast cancer cells |
| 006D45 (1992) |
R. L. Sutherland [Australie] ; C. S. L. Lee ; R. S. Feldman ; E. A. Muscogrove | Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists |
